Whitney Ijem

Analyst-Equity presso

Canaccord Genuity LLC

Finance

Consumer Services

Health Technology

Profilo

Whitney G.
Ijem is currently an Analyst at Canaccord Genuity LLC since 2022.
Formerly, Ms. Ijem was Vice President at JPMorgan Securities LLC; Analyst at Guggenheim Securities LLC from 2018 to 2020; Research Analyst at Canaccord Genuity, Inc. from 2012 to 2013; Healthcare Analyst at Tourbillon Capital Partners LP; and Senior VP-Strategy & Business Development at Krystal Biotech, Inc. from 2020 to 2022.
Ms. Ijem completed undergraduate studies at Washington University in St. Louis in 2009 and graduate studies at New York University in 2011.

Posizioni attive di Whitney Ijem

Società	Posizione	Inizio
Canaccord Genuity LLC Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	01/07/2022

Tutte le posizioni attive di Whitney Ijem

Precedenti posizioni note di Whitney Ijem

Società	Posizione	Fine
KRYSTAL BIOTECH, INC.	Contatto Relazioni con gli Investitori	01/04/2022
Guggenheim Securities LLC Guggenheim Securities LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	01/07/2020
Canaccord Genuity, Inc. Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	31/03/2013
Tourbillon Capital Partners LP Tourbillon Capital Partners LP Investment ManagersFinance Tourbillon Capital Partners seeks to generate superior risk-adjusted returns while maintaining lower volatility than, and limited correlation to, the equity markets. The firm generally employs a fundamentally-driven and low net-exposure long/short investment approach. They are also opportunistic in their approach, using a multi-disciplinary investment process across four primary long/short trade-types: low beta long/short; long/short relative value; equity special situations; and tactical trading opportunities. The Tourbillon Master Fund generally focuses on investments that can be easily liquidated in normal markets. Investments typically include liquid, listed equity and equity-linked securities in global, developed markets where shorting is permissible. While Tourbillon may trade credit-related instruments, such as credit default swaps, and other non-equity instruments, such as commodities and currencies, they expect to use these instruments for hedging purposes or as related to an equity investment idea. Tourbillon may use leverage to seek to enhance the return of their investments. The amount of leverage varies with the number and quality of investment opportunities available to the fund and with Tourbillon's perceived risk level of the portfolio. The fund's gross exposure generally ranges from 150%-300%, although it may be substantially higher or lower.	Corporate Officer/Principal	-
JPMorgan Securities LLC JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	-

Vedi nel dettaglio l'esperienza di Whitney Ijem

Formazione di Whitney Ijem

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Whitney Ijem

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	8
Washington University in St. Louis Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
JPMorgan Securities LLC JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Guggenheim Securities LLC Guggenheim Securities LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Canaccord Genuity, Inc. Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services	Finance
Tourbillon Capital Partners LP Tourbillon Capital Partners LP Investment ManagersFinance Tourbillon Capital Partners seeks to generate superior risk-adjusted returns while maintaining lower volatility than, and limited correlation to, the equity markets. The firm generally employs a fundamentally-driven and low net-exposure long/short investment approach. They are also opportunistic in their approach, using a multi-disciplinary investment process across four primary long/short trade-types: low beta long/short; long/short relative value; equity special situations; and tactical trading opportunities. The Tourbillon Master Fund generally focuses on investments that can be easily liquidated in normal markets. Investments typically include liquid, listed equity and equity-linked securities in global, developed markets where shorting is permissible. While Tourbillon may trade credit-related instruments, such as credit default swaps, and other non-equity instruments, such as commodities and currencies, they expect to use these instruments for hedging purposes or as related to an equity investment idea. Tourbillon may use leverage to seek to enhance the return of their investments. The amount of leverage varies with the number and quality of investment opportunities available to the fund and with Tourbillon's perceived risk level of the portfolio. The fund's gross exposure generally ranges from 150%-300%, although it may be substantially higher or lower.	Finance
Krystal Biotech, Inc. Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases	Health Technology
Canaccord Genuity LLC Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services	Finance